Ipca Laboratories said that it has entered into a technology transfer agreement with Omexa Formulary private for a biosimilar clone, process development.
Subscribe To Our Free Newsletter |
Ipca Laboratories said that it has entered into a technology transfer agreement with Omexa Formulary private for a biosimilar clone, process development.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!